drugset / Trial / NCT00385658

Efficacy of Fluvastatin and Fenofibrate in Comparison to Simvastatin and Ezetimibe in Patients With Metabolic Syndrome

NCT00385658

Phase 4 Completed 75 enrolled Novartis
RandomizedCrossoverOpen-labelTreatment

Summary

This study will investigate the effects of the combination of fluvastatin and fenofibrate on dyslipidemia in comparison to the combination of simvastatin and ezetimibe.

Timeline

Start
2006-08
Primary completion
2007-03
Completion
2007-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Ezetimibe Unknown
Subject Fenofibrate Small molecule
Subject Fluvastatin Other / unclassified
Subject Simvastatin Small molecule

Indications